X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs GSK PHARMA - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS GSK PHARMA NOVARTIS/
GSK PHARMA
 
P/E (TTM) x 265.8 56.4 470.9% View Chart
P/BV x 22.6 10.1 224.2% View Chart
Dividend Yield % 1.6 1.3 128.5%  

Financials

 NOVARTIS   GSK PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-17
GSK PHARMA
Mar-17
NOVARTIS/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs8553,838 22.3%   
Low Rs6662,637 25.2%   
Sales per share (Unadj.) Rs219.0354.2 61.8%  
Earnings per share (Unadj.) Rs19.139.8 48.0%  
Cash flow per share (Unadj.) Rs20.342.9 47.3%  
Dividends per share (Unadj.) Rs10.0030.00 33.3%  
Dividend yield (eoy) %1.30.9 141.9%  
Book value per share (Unadj.) Rs307.0236.9 129.6%  
Shares outstanding (eoy) m29.9684.70 35.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.59.1 38.0%   
Avg P/E ratio x39.881.4 48.9%  
P/CF ratio (eoy) x37.575.5 49.6%  
Price / Book Value ratio x2.513.7 18.1%  
Dividend payout %52.475.4 69.4%   
Avg Mkt Cap Rs m22,779274,216 8.3%   
No. of employees `0000.74.7 14.3%   
Total wages/salary Rs m1,3934,830 28.8%   
Avg. sales/employee Rs Th9,736.26,387.0 152.4%   
Avg. wages/employee Rs Th2,066.81,028.3 201.0%   
Avg. net profit/employee Rs Th849.0717.1 118.4%   
INCOME DATA
Net Sales Rs m6,56230,000 21.9%  
Other income Rs m702728 96.3%   
Total revenues Rs m7,26430,728 23.6%   
Gross profit Rs m2594,190 6.2%  
Depreciation Rs m36263 13.7%   
Interest Rs m70-   
Profit before tax Rs m9174,655 19.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m3451,744 19.8%   
Profit after tax Rs m5723,368 17.0%  
Gross profit margin %3.914.0 28.2%  
Effective tax rate %37.637.5 100.4%   
Net profit margin %8.711.2 77.7%  
BALANCE SHEET DATA
Current assets Rs m9,73116,742 58.1%   
Current liabilities Rs m1,8307,202 25.4%   
Net working cap to sales %120.431.8 378.6%  
Current ratio x5.32.3 228.7%  
Inventory Days Days4952 94.0%  
Debtors Days Days2521 121.1%  
Net fixed assets Rs m578,635 0.7%   
Share capital Rs m141847 16.6%   
"Free" reserves Rs m9,05619,222 47.1%   
Net worth Rs m9,19620,069 45.8%   
Long term debt Rs m010 0.0%   
Total assets Rs m11,49930,038 38.3%  
Interest coverage x128.4NM-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.61.0 57.1%   
Return on assets %5.011.2 44.9%  
Return on equity %6.216.8 37.1%  
Return on capital %10.125.5 39.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m129528 24.4%   
Fx outflow Rs m1,7347,193 24.1%   
Net fx Rs m-1,605-6,665 24.1%   
CASH FLOW
From Operations Rs m-3802,360 -16.1%  
From Investments Rs m4,2083,008 139.9%  
From Financial Activity Rs m-3,318-5,108 65.0%  
Net Cashflow Rs m510260 196.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 50.7 147.9%  
Indian inst/Mut Fund % 2.0 10.2 19.6%  
FIIs % 1.6 23.8 6.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 15.4 139.6%  
Shareholders   41,647 102,036 40.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   TORRENT PHARMA  NATCO PHARMA  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  ALEMBIC PHARMA  

Compare NOVARTIS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Cheap Valuation of PSU Banks and Key Stocks in Action Today(Pre-Open)

NSE PSU Bank Index surged 30% on 25th October 2017-the date when bank recapitalization of Rs 2.1 trillion was announced.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


May 18, 2018 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS